Quest Diagnostics (DGX) Reports In-Line Q2 EPS, Slight Revenue Miss; Narrows FY18 EPS Outlook, Lowers FY18 Revenue Mid-Point Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

Go back to Quest Diagnostics (DGX) Reports In-Line Q2 EPS, Slight Revenue Miss; Narrows FY18 EPS Outlook, Lowers FY18 Revenue Mid-Point Guidance

Quest Diagnostics (DGX) PT Raised to $122 at Canaccord Genuity

July 23, 2018 5:58 AM EDT

Canaccord Genuity raised its price target on Quest Diagnostics (NYSE: DGX) to $122.00 (from $118.00) while maintaining a Buy rating.

... More